LDS/Medical Tests/Immunoglobulin A (IgA)

Immunoglobulin A (IgA)

Immunoglobulin A (IgA) is an antibody that plays a crucial role in the immune function of mucous membranes. It comprises about 15% of serum gamma globulins. As a major secretory immunoglobulin in our body this class of immunoglobulins serves as the primary antibody in saliva, tears, milk, gastrointestinal and respiratory mucosa. IgA plays an important role in protection of mucosal lining from infection. There are two classes: IgA1 and IgA2. IgA usually circulates in serum as a single unit; however, it is usually in less concentration in secretory fluids. Increased monoclonal IgA is seen in lymphoproliferative disorders such as multiple myeloma, lymphoma and leukemia. Monoclonal IgA is also seen in “Mediterranean” lymphoma involving bowel and monoclonal gammopathy of undetermined significance (MGUS).

IgA is the second most frequent type of monoclonal immunoglobulin in multiple myeloma. IgA may be elevated in a wide range of conditions affecting mucosal surfaces where IgA is produced. Increased levels of IgA are also commonly seen in chronic liver disease such as primary biliary cirrhosis, in chronic infections, chronic inflammatory diseases including inflammatory bowel disease, rheumatoid arthritis, other connective tissue diseases and sarcoidosis.

Idiopathic IgA nephropathy (Berger Disease) is the most common primary glomerulonephritis caused by elevated levels of IgA deposited in glomerular mesangial membranes.

Decreased levels of IgA (IgA deficiency) results in respiratory bacterial infections. IgA deficiency is closely associated with diarrheal parasitic disease giardiasis. IgA deficiency is seen in hereditary telangiectasia, type III dysgammaglobulinemia, systematic lupus erythematosus (SLE), Still’s disease, Waldenstrom macroglobulinemia, gastric carcinoma and in celiac disease (especially in children).

  • As an aid in diagnosis and management of monoclonal gammopathies such as multiple myeloma
  • Evaluate anaphylaxis associated with transfusion of blood and blood products
  • As an aid in diagnosis of Celiac diseases
  • As an aid in diagnosis of IgA nephropathy
  • As an aid in diagnosis of psoriatic arthritis
  • As an aid in diagnosis of Monoclonal gammopathy of undetermined significance
  • Helpful in determining the reason for persistent infections

Increased in:

  • Monoclonal gammopathy of undetermined significance (MGUS)
  • Multiple myeloma
  • Some autoimmune diseases:
  • Rheumatoid arthritis (RA)
  • Systemic lupus erythematosus (SLE)
  • Some liver diseases:
  • Cirrhosis
  • Chronic hepatitis
  • Primary systemic amyloidosis
  • Inflammatory bowel diseases
  • Sarcoidosis
  • Wiskott-Aldrich syndrome
  • Lymphoma
  • Chronic lymphocytic leukemia
  • Ankylosing spondylitis

Decreased in:

  • Liver cirrhosis
  • Nephrotic syndrome
  • Type III dysgammaglobulinemia
  • Enteropathy
  • Ataxia-telangiectasia
  • Primary or secondary immune disorders
  • Waldenstrom macroglobulinemia
  • Acquired immunodeficiency
  • Gastric carcinoma

0-1 years 0-83 mg/dl

1-3 years 20-100 mg/dl

4-6 years 27-195 mg/dl

7-9 years 34-305 mg/dl

10-11 years 53-204 mg/dl

12-13 years 58-358 mg/dl

14-15 years 47-305 mg/dl

16-18 years 78-348 mg/dl

≥19 years 85-400mg/dl

Nephelometry, Indirect immunofluorescence, enzyme-linked immunosorbent assay (ELISA).

Serum (SST). 

Stability

  • Ambient: 48 hours
  • Refrigerated: 7 days
  • Frozen: 28 days
Serum protein electrophoresis may be used to monitor treatment, Immunoglobulin G (IgG), Complement components, glomerular basement membrane antibody, Liver functional panel.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Nat Rev Immunol. 2003 Jan;3(1):63-72. [PMID: 12511876]
  • J Biol Chem. 2009 Feb 20;284(8):5077-87. [PMID: 19109255]
  • Semin Immunol. 2007 Apr;19(2):127-35. [PMID: 17161619]
  • Curr Opin Immunol. 2008 Apr;20(2):170-7. [PMID: 18456485]
  • Trends Immunol. 2008 Nov;29(11):523-31. [PMID: 18838301]
  • Mary Williamson, L. Michael Snyder. Wallach’s Interpretation of Diagnostic Testing, 9th ed. Lippincott Williams and Wilkins (Wolters Kluwer); 2011